Primary outcome
|
Cotinine level
| |
X
| | | |
X
|
Secondary outcomes
|
Nicotine dependence (Fagerström)
|
X
| | |
X
|
X
| |
MAP-HSS + smoking related complaints of smokers
|
X
| | |
X
|
X
|
X
|
Depression, anxiety and stress (DASS21)
|
X
| | |
X
|
X
|
X
|
Quality of Life (Euroqol 5D)
|
X
| | |
X
| | |
Smoking status
|
X
|
X
| |
X
|
X
|
X
|
Adherence
| | | | | |
X
|
Costs
| | | | | |
X
|
Baseline predictors and moderators of treatment effect
|
Internet Skills
|
X
| | | | | |
Readiness to change
|
X
| | | | | |
Attitude
|
X
| | |
X
|
X
| |
Social Influence
|
X
| | | | | |
Self-Efficacy
|
X
| | |
X
| | |
Alcohol/substance (mis)use
|
X
| | |
X
| | |
Descriptive variables
|
Patient characteristics and medical history
|
X
| | | | | |
Smoking history
|
X
| | | | | |
Stop Smoking History
|
X
| | | | | |
Other information of interest
|
Evaluation of treatment
| |
X
| |
X
|
X
|
X
|
Exhaled carbon monoxide (CO) level
|
X
|
X
|
X
| | |
X
|